US Patent Issued to Yunnan Precious Metals Laboratory, Kunming Medical University on Sept. 1 for "Oral Pt (IV) anticancer prodrug containing 3-bromopyruvate as axial ligand" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,855, issued on Sept. 1, was assigned to Yunnan Precious Metals Laboratory Co. Ltd (Kunming, China) and Kunming Medical University (Kunming, China).

"Oral Pt (IV) anticancer prodrug containing 3-bromopyruvate as axial ligand" was invented by Weiping Liu (Kunming, China), Chen Qing (Kunming, China), Anli Gao (Kunming, China), Peng Zhou (Kunming, China), Jing Jiang (Kunming, China), Hongyu Zhou (Kunming, China), Juan Yu (Kunming, China) and Lingling Zhang (Kunming, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an oral Pt(IV) anticancer prodrug containing a 3-bromopyruvate as an axial ligand, with a molecular formula of cis,trans,cis-...